PFM Health Sciences’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
KCM
PFM Health Sciences's SNDX Position: Q3 2026 in Review
PFM Health Sciences sold out of Syndax Pharmaceuticals (SNDX) in Q3 2026, closing a stake of 118,422 shares — an estimated $2.59M sold.
PFM Health Sciences first reported a position in SNDX in Q1 2021 and held it in 21 quarters. The position peaked at $46.2M in Q4 2022. 237 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.
- PFM Health Sciences reported no remaining Syndax Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- PFM Health Sciences sold 118,422 Syndax Pharmaceuticals shares in Q3 2026, an estimated $2.59M.
- PFM Health Sciences first reported a position in Syndax Pharmaceuticals in Q1 2021 and held it in 21 quarters.
- PFM Health Sciences's Syndax Pharmaceuticals position peaked at $46.2M in Q4 2022.
- 237 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.
Based on PFM Health Sciences's 13F filing for Q3 2026, filed 16 Nov 2026.